183 related articles for article (PubMed ID: 11156849)
21. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
[TBL] [Abstract][Full Text] [Related]
22. New targets for antithrombotic drugs.
Thiagarajan P
Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
25. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.
Andre P; Delaney SM; LaRocca T; Vincent D; DeGuzman F; Jurek M; Koller B; Phillips DR; Conley PB
J Clin Invest; 2003 Aug; 112(3):398-406. PubMed ID: 12897207
[TBL] [Abstract][Full Text] [Related]
26. Endogenous mediators and thrombophilia.
Smith RE; Martin JF
Baillieres Clin Haematol; 1994 Sep; 7(3):485-97. PubMed ID: 7841597
[TBL] [Abstract][Full Text] [Related]
27. Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
Leopold JA; Loscalzo J
Coron Artery Dis; 1995 Dec; 6(12):923-9. PubMed ID: 8723013
[No Abstract] [Full Text] [Related]
28. Activation of platelet function through G protein-coupled receptors.
Offermanns S
Circ Res; 2006 Dec; 99(12):1293-304. PubMed ID: 17158345
[TBL] [Abstract][Full Text] [Related]
29. Platelet activation and interactions with the microvasculature.
Body SC
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S13-25. PubMed ID: 8938279
[TBL] [Abstract][Full Text] [Related]
30. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
Montalescot G
Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
[TBL] [Abstract][Full Text] [Related]
31. Platelets and platelet-derived microparticles in vascular inflammatory disease.
Vasina E; Heemskerk JW; Weber C; Koenen RR
Inflamm Allergy Drug Targets; 2010 Dec; 9(5):346-54. PubMed ID: 21054257
[TBL] [Abstract][Full Text] [Related]
32. Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis.
Alvarez A; Rios-Navarro C; Blanch-Ruiz MA; Collado-Diaz V; Andujar I; Martinez-Cuesta MA; Orden S; Esplugues JV
Antiviral Res; 2017 May; 141():179-185. PubMed ID: 28263802
[TBL] [Abstract][Full Text] [Related]
33. Novel endogenous negative modulators of platelet function as potential anti-thrombotic targets.
Li YJ; Zhu HX; Zhang D; Li HC; Ma P; Huang LY
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3146-3158. PubMed ID: 28742189
[TBL] [Abstract][Full Text] [Related]
34. New antithrombotic strategies for resistant thrombotic processes.
Harker LA
J Clin Pharmacol; 1994 Jan; 34(1):3-16. PubMed ID: 8132848
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo.
Hsiao G; Shen MY; Lin KH; Chou CY; Tzu NH; Lin CH; Chou DS; Chen TF; Sheu JR
Eur J Pharmacol; 2003 Apr; 465(3):281-7. PubMed ID: 12681440
[TBL] [Abstract][Full Text] [Related]
36. Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion.
Klauss V; Spannagl M
Curr Drug Targets; 2006 Oct; 7(10):1285-90. PubMed ID: 17073589
[TBL] [Abstract][Full Text] [Related]
37. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
38. Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis.
White JG
Cardiovasc Clin; 1987; 18(1):13-33. PubMed ID: 3607810
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet drugs in arterial thrombosis: a review.
Tsu EC
Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
